Skip to main content

Table 2 Mean BUN at baseline, week 16 and corresponding differences with confidence intervals

From: Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats

BUN (mg/dl)BaselineWeek 16Difference (%)
Placebo16.9 ± 2.119.4 ± 1.819 ± 27
Everolimus15.7 ± 2.018.3 ± 1.215 ± 11
Placebo + [177Lu]Lu-DOTA-TATE17.9 ± 1.719.1 ± 2.27 ± 10
Everolimus + [177Lu]Lu-DOTA-TATE16.9 ± 1.319.9 ± 1.119 ± 12